Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine plus oxycodone for refractory headache and neuropathic pain
MOH_2020-07-07_009117Phase 2Not yet recruiting
- Sponsor
- פרופ' תמיר בן חור
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ketamine and oxycodone in headache disorder and Neuralgia, sponsored by פרופ' תמיר בן חור. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
ketamineoxycodone
03
Conditions
headache disorderNeuralgia
Beyond the preview
Go deeper on MOH_2020-07-07_009117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-07-07_009117.